What programs assist with vascepa's cost?

How do patient assistance programs handle Vascepa prescriptions?

Amarin runs a patient assistance program that supplies free Vascepa to qualifying uninsured or under-insured U.S. patients who meet income guidelines.

Where can patients find manufacturer copay support?

The Vascepa Savings Card reduces out-of-pocket costs for commercially insured patients to as little as $9 for a 90-day fill, subject to annual maximums and eligibility rules.

What happens when commercial coverage is denied?

Amarin’s program offers a bridge supply while appeals or alternative coverage options are pursued, but continued free medication depends on ongoing qualification reviews.

Can Medicare or Medicaid recipients use these programs?

Patients with government insurance are generally ineligible for the savings card; however, some state Medicaid programs may cover Vascepa or offer supplemental assistance through case management.

Are there nonprofit or independent resources available?

Organizations such as the Patient Access Network Foundation and the HealthWell Foundation maintain funds that may offset copays for eligible patients after commercial or government coverage is applied.

When do patents and exclusivity affect program availability?

Vascepa’s key patents expired in 2020, allowing generic icosapent ethyl products to reach the market; generic availability has reduced average cash prices and may change how assistance programs prioritize brand-name supply.